4.1. Materials and Methods
All reagents were obtained from commercial sources and used without further purification. Melting points were determined on a Mettler Toledo MP70 Melting Point System (Mettler Toledo, Columbus, OH, USA) and are uncorrected. Proton nuclear magnetic resonance (
1H NMR, 400 MHz) and carbon nuclear magnetic resonance (
13C NMR, 100 MHz) spectra were recorded on a Varian 400 wide-bore spectrometer (Varian, Palo Alto, CA, USA) in CDCl
3 (unless otherwise noted) with the values given in ppm and
J (Hz) assignments of
1H resonance coupling. For
1H NMR spectra (CDCl
3), the residual solvent peak was used as the reference (7.26 ppm) while the central solvent peak was used as the NMR reference (77.0 ppm in CDCl
3). The high-resolution mass spectra were obtained on a Waters (Waters Corp., Milford, MA USA) LCT Premier Time-of-Flight (TOF) mass spectrometer using electrospray ionization (ESI). Thin-layer chromatography (TLC) was performed on 0.25 mm Analtech GHLF silica gel and was used to determine the completion of the reaction depending on the polarity of the compounds, using CHCl
3: MeOH: 28% NH
4OH, 90:9:1. Gas chromatography (GC) was performed on an Agilent Technologies 6850 Series system (Agilent Technologies, Santa Clara, CA, USA) equipped with Agilent Technologies 7683B series injector and Agilent Technologies 5975C VL MSD Triple-Axis detector. Flash column chromatography was performed using Teledyne Isco prepacked silica gel (RediSep) columns (Teledyne Isco, Lincoln, NE, USA). Elemental analyses were performed by Micro-Analysis, Inc, Wilmington, DE, USA, and were within ±0.4% for C, H, and N.
1H and
13C NMRs of novel compounds and X-ray crystallographic data for compound
16 can be found in the
Supplementary Material.
The materials and reagents used for the biological evaluation of the haptens are the following: the NHS-(PEG)2-maleimide crosslinker [(SM-(PEG)2], spin desalting columns (ZebaTM, 7K MWCO), dialysis cassettes (Slide-A-LyzerTM, 10K MWCO), PierceTM bicinchoninic acid (BCA) protein assay kit, and the bovine serum albumin (BSA) that was used for coupling reactions were purchased from Fisher Scientific (Rockford, IL, USA). Tetanus toxoid (TT) was purchased from Statens Serum Institut (Copenhagen, Denmark). Dulbecco’s phosphate-buffered saline (DPBS, pH 7.4) was purchased from Quality Biological Inc. (Gaithersburg, MD, USA,). Lipids used to prepare liposomal adjuvant, 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), synthetic monophosphoryl lipid A (PHAD®) (MPLA), and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Alhydrogel® was purchased from Brenntag (Reading, PA, USA). Mouse anti-tetanus toxoid monoclonal antibody was purchased from Abcam (Cambridge, MA, USA). Peroxidase-linked sheep anti-mouse IgG (γ-chain specific) was purchased from The Binding Site (San Diego, CA, USA). The 2,2′-Azino-di(3-ethylbenzthiazoline-6-sulfonate) (ABTS) peroxidase substrate system was purchased from KPL, Inc. (Gaithersburg, MD, USA). Mass spectrometry grade water and acetonitrile (ACN), methanol (MeOH), and rapid equilibrium dialysis (ED) plates (12 kDa MWCO) were purchased from Fisher Scientific (Rockford, IL, USA). Sodium fluoride was purchased from Sigma-Aldrich (Milwaukee, WI, USA). Mass spectrometry standards, heroin-d5, 6-acetylmorphine-d3, morphine-d3 d,l-methadone, and buprenorphine·HCl, were from Lipomed Inc. (Cambridge, MA, USA. Naloxone-d5 and naltrexone-d3 were from Cerilliant (Round Rock, TX, USA).
N-((4R,4aR,7R,7aR,12bS)-7-Acetamido-9-hydroxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-11-yl)-3-(tritylthio)propanamide (1). To a solution of 17 (0.728 g, 2.05 mmol) in CHCl3 (40 mL) at −78 °C was added BBr3 (2.56 g, 10.25 mmol) and the solution was stirred at room temperature overnight. The reaction was quenched with MeOH and the solvent was removed in vacuo. MeOH (20 mL) was added and the solvent was removed in vacuo. The procedure was repeated three times. The crude product was treated with CHCl3 (50 mL) and 3-(tritylthio)propanoic acid (1.07 g, 3.07 mmol), Et3N (1.04 g, 1.42 mL, 10.2 mmol), O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TBTU, 1.32 g, 4.1 mmol) were added. After stirring overnight, the solvent was removed in vacuo and the residue was dissolved in THF (20 mL) and 28% NH4OH (5 mL) was added. The mixture was heated to 50 °C overnight. The solvent was removed in vacuo, the residue was treated with CHCl3 (100 mL) and the solution was washed with saturated NaHCO3 and brine and dried over anhydrous Na2SO4. After filtration and removal of solvent in vacuo, the residue was purified by flash chromatography (CHCl3:MeOH:NH4OH, 90:9:1) to afford hapten 1 (0.43 g, 31.1% over 3 steps) as yellow solid. [α]D20 −75.0° (c 1.0, CHCl3:MeOH, 19:1); 1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 7.6 Hz, 6H), 7.25 (t, J = 8.0 Hz, 6H), 7.18 (t, J = 7.2 Hz, 3H), 6.72 (s, 1H), 5.66 (m, 1H), 5.49 (d, J = 10.4 Hz, 1H), 4.54 (s, 1H), 4.30 (d, J = 5.6 Hz, 1H), 3.24 (m, 1H), 2.86 (m, 2H), 2.54 (m, 3H), 2.31 (m, 4H), 2.16 (t, J = 7.2 Hz, 2H), 2.04 (dd, J = 18.4, 6.0 Hz, 1H), 1.93 (m, 4H), 1.74 (d, J = 11.6 Hz, 1H); 13C NMR (100 MHz, CDCl3+CD3OD) δ 170.8, 169.5, 144.7 (3), 142.8, 139.2, 131.9, 130.0, 129.6 (6), 128.6, 128.0 (6), 127.1, 126.8 (3); 119.4, 113.1, 93.1, 67.0, 58.9, 47.0, 44.1, 42.9, 39.2, 36.0, 35.3, 28.0, 22.94, 22.89, 18.0; MS (ESI): m/z 672.3 [M + H]+. HRMS (ESI) m/z calcd for C41H42N3O4S 672.2891, found 672.2891; Anal. calcd. for C41H41N3O4S•1.0 t-BuOH•0.5H2O: C, 71.59; H, 6.94; N, 5.57. Found: C, 71.50; H, 7.04; N, 5.78 (after 1 was lyophilized from t-BuOH).
N-((4R,4aR,7S,7aR,12bS)-7-Acetamido-9-hydroxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-11-yl)-3-(tritylthio)propanamide (2). To a solution of silanol 25 (0.116 g, 0.127 mmol) in THF (2 mL) was added 1.0 M tetrabutylammonium fluoride solution (0.510 mL, 0.508 mmol, 4 equiv). The solution was stirred for 16 h and then concentrated in vacuo to give a brown oil. The oil was purified by silica gel chromatography (CHCl3:MeOH:28% NH4OH, 99:0.9:0.1 to 90:9:1) to give hapten 2 as a clear oil (0.048 g, 56%). The oil was lyophilized in tert-butanol to give hapten 2 as a white powder suitable for biological studies. [α]D20 −0.726° (c 0.65, MeOH); 1H NMR (400 MHz; CDCl3) δ 7.41 (d, J = 7.7 Hz, 5H), 7.36–7.17 (m, 10H), 7.09 (s, 1H), 6.71 (d, J = 8.6 Hz, 1H), 5.37 (d, J = 9.4 Hz, 1H), 5.23 (d, J = 9.5 Hz, 1H), 4.75 (d, J = 6.1 Hz, 1H), 4.48 (s, 1H), 3.33 (d, J = 2.0 Hz, 1H), 2.80 (d, J = 18.0 Hz, 1H), 2.66 (s, 1H), 2.57 (dd, J = 10.6, 6.0 Hz, 3H), 2.32 (s, 4H), 2.16 (t, J = 6.7 Hz, 2H), 2.08–2.02 (m, 2H), 1.96 (s, 3H), 1.75 (d, J = 12.8 Hz, 1H); 13C NMR (100 MHz; CDCl3) δ 170.3, 169.8, 144.5, 143.5, 138.7, 130.80, 130.66, 129.5, 128.0, 127.6, 126.8, 118.1, 111.7, 90.5, 67.1, 58.5, 47.2, 46.3, 43.6, 42.9, 36.3, 27.9, 23.1, 18.1; HRMS (ESI) (m/z) calcd for C41H42N3O4S, 672.2896; found 672.2897. Anal calcd for C41H41N3O4S•1.0 t-BuOH•1.45 H2O: C, 70.00; H, 7.04; N, 5.44; found C, 69.90; H, 6.86; N, 5.54.
N-((4R,4aR,7S,7aR,12bS)-7-acetamido-9-hydroxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-11-yl)-3-(tritylthio)propanamide (3). To a solution of 32 (400 mg, 1.07 mmol) in MeOH (20 mL) was added 10% (w/w) Pd/C (200 mg). The reaction mixture was stirred under H2 atmosphere (40 psi) for 5 h at room temperature. The mixture was filtered through a Celite pad, and the solvent was concentrated in vacuo to give the crude intermediate amine 3 (N-((4R,4aR,7S,7aR,12bS)-11-amino-9-hydroxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide) as a yellow solid that was used without purification. The intermediate 3 was dissolved in DCM (20 mL) and Et3N (4.2 mL). 3-(tritylthio)propanoic acid (1.12 g, 3.21 mmol, 3 equiv) and O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium tetrafluoroborate (TBTU, 1.20 g, 3.74 mmol, 3.5 equiv) were added to the reaction mixture, and the mixture was stirred at room temperature for 16 h. The reaction was quenched with saturated NaHCO3 (20 mL) and extracted with DCM (3 × 25 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered, and solvent removed in vacuo. The residual material was dissolved in THF (10 mL) and 28% NH4OH (6 mL) and heated at 60 °C for 5 h. After cooling to room temperature, H2O (15 mL) was added, and the mixture was extracted with CHCl3:MeOH (6:1) (3 × 30 mL). The combined organic layers were dried over MgSO4, filtered, concentrated in vacuo, and the product was purified through silica gel chromatography (CHCl3:MeOH:28% NH4OH, 90:9:1)) to give hapten 3 (495 mg, 69% yield) as a pale brown solid, mp 170–174 °C. [α]20D −66.5° (c 1.0, CHCl3); HRMS (ESI) m/z 674.3049 [C41H44N3O4S (M+H) requires 674.3052; 1H NMR (400 MHz, CDCl3) δ 7.49–7.12 (m, 16H), 6.07 (d, J = 9.0 Hz, 1H), 4.58 (d, J = 4.3 Hz, 1H), 4.25–4.10 (m, 1H), 3.10 (d, J = 3.5 Hz, 1H), 2.73 (d, J = 18.1 Hz, 1H), 2.61 (t, J = 6.8 Hz, 2H), 2.50 (dd, J = 11.7, 3.8 Hz, 1H), 2.35–2.09 (m, 8H), 1.99–1.85 (m, 4H), 1.67–1.59 (m, 2H), 1.45–1.40 (m, 1H), 1.08–0.98 (m, 1H), 0.84–0.76 (m, 1H); 13C NMR (400 MHz, CDCl3) δ 169.8, 169.7, 144.4, 143.1, 138.3, 129.9, 129.5, 128.0, 127.5, 126.8, 117.8, 111.6, 89.9, 67.1, 59.2, 46.6, 46.0, 42.9, 42.9, 37.1, 36.4, 35.9, 27.9, 23.3, 22.0, 20.2, 17.5. Anal. calcd for C41H43N3O4S•1.25 H2O: C, 70.71; H, 6.59; N, 6.03, found C, 70.86; H, 6.55; N, 6.03.
N-((4R,4aR,7R,7aR,12bS)-7-acetamido-9-hydroxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-11-yl)-3-(tritylthio)propanamide (4). A mixture of the amine 34 (105 mg, 0.31 mmol), 3-(tritylthio)propanoic acid (160 mg, 0.46 mmol), Et3N (0.13 mL, 0.92 mmol) and TBTU (196 mg, 0.61 mmol) in CH2Cl2 (20 mL) was stirred at room temperature overnight, and then 50 °C for 3 h. The solution was diluted with CH2Cl2 (80 mL) and washed with saturated NaHCO3 and brine and dried over Na2SO4. After filtration and removal of solvent in vacuo, the residual material was purified by flash chromatography (CHCl3:MeOH:NH4OH, 90:9:1) to give hapten 4 (147 mg, 71.4%). [α]D20 −97.8° (c 0.99, CHCl3:MeOH 19:1); 1H NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.0 Hz, 6H), 7.28 (t, J = 8.0 Hz, 6H), 7.21 (t, J = 7.2 Hz, 3H), 6.15 (s, 1H), 5.68 (d, J = 7.2 Hz, 1H), 4.48 (d, J = 8.0 Hz, 1H), 3.39 (brs, 2H), 3.18 (m, 2H), 2.70 (d, J = 18.0 Hz, 1H), 2.51 (m, 5H), 2.38 (s, 3H), 2.16 (td, J = 12.0, 4.0 Hz, 1H), 2.07 (dd, J = 18.0, 5.6 Hz, 1H), 1.83 (m, 5H), 1.71 (dd, J = 12.4, 2.0 Hz, 1H), 1.61 (m, 1H), 1.50 (m, 1H), 0.80–1.01 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 170.3, 169.6, 144.8, 139.6, 137.6, 133.7, 131.8, 129.7 (6), 128.1 (6), 126.9 (3), 118.0, 107.4, 92.9, 67.0, 59.1, 53.4, 47.2, 43.9, 43.0, 42.7, 35.1, 33.4, 28.3, 27.0, 24.6, 23.9, 17.3; MS (ESI): m/z = 674.3 [M + H]. HRMS (ESI) m/z calcd for C41H44N3O4S 674.3047; found, 674.3048; Anal. calcd for C41H43N3O4S•1.0 t-BuOH•0.55 H2O: C, 71.31; H, 7.19; N, 5.54. Found: C, 71.26; H, 7.06; N, 5.63, after lyophilization from t-BuOH.
(4R,4aR,7R,7aR,12bS)-7-Acetamido-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl acetate (
6). To a solution of the known phenolic amine
5 [23] in CHCl
3 (30 mL) at 0 °C was added a solution of Et
3N (4.4 g, 6 mL, 43 mmol) and Ac
2O (2.35 g, 2.2 mL, 23 mmol), and these were stirred at room temperature overnight, washed with a dilute solution of NaHCO
3, H
2O and brine, successively and dried over anhydrous Na
2SO
4. The crude product was purified by flash chromatography (CHCl
3:MeOH:28% NH
4OH, 90:9:1) to give the acetate
6 (2.42 g, 68% over 4 steps from morphine) as a white foam.
1H NMR (400 MHz, CDCl
3)
δ 6.71 (d,
J = 8.0 Hz, 1H), 6.53 (d,
J = 8.0 Hz, 1H), 5.78 (m, 2H), 5.56 (dd,
J = 10.0, 2.0 Hz, 1H), 4.74 (s, 1H), 4.33 (t,
J = 6.4 Hz, 1H), 3.29 (m, 1H), 3.01 (d,
J = 18.8 Hz, 1H), 2.96 (s, 1H), 2.52 (dd,
J = 12.4, 4.0 Hz, 1H), 2.38 (s, 3H), 2.29 (m, 2H), 2.20 (s, 3H), 1.97 (d,
J = 12.4, 5.2 Hz, 1H), 1.92 (s, 3H), 1.78 (dd,
J = 12.6, 2.0 Hz, 1H).
13C NMR (100 MHz, CDCl
3)
δ 169.9, 168.6, 148.9, 132.7, 132.4, 131.8, 131.4, 128.9, 121.9, 119.0, 93.2, 58.9, 49.6, 46.7, 44.1, 43.1, 40.2, 35.8, 23.2, 20.7, 20.6; MS (ESI)
m/
z = 369.2 [M + H]; HRMS (ESI) (
m/
z) calcd for C
21H
25N
2O
4 369.1809; found 369.1810.
(4R,4aR,7R,7aR,12bS)-7-Acetamido-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl acetate (7). To a solution of acetate 6 (1.09 g, 2.96 mmol) in CH3NO2 (60 mL) at −20 °C was added a mixture of HNO3 (0.75 g, 0.5 mL) and concentrated H2SO4 (1.3 mL) and the mixture was stirred at −20~−10 °C for 1 h. The mixture was diluted with H2O and basified with NaHCO3 powder. The two-layer mixture was extracted with CH2Cl2. The combined extracts were washed with H2O and brine and dried over anhydrous Na2SO4. After filtration and removal of solvent in vacuo, the residue was purified by flash chromatography (CHCl3:MeOH:NH4OH, 90:9:1) to afford three fractions containing 7 (152 mg, 12.4%), 8 (202 mg, 18.4%) and 9 (420 mg, 34.1%). Compound 7: yellow foam; [α]D20 −132.3° (c 1.01, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.86 (s, 1H), 5.86 (m, 1H), 5.64 (m, 2H), 4.93 (s, 1H), 4.37 (t, J = 6.4 Hz, 1H), 3.54 (d, J = 20.0 Hz, 1H), 3.38 (m, 1H), 3.01 (s, 1H), 2.67 (dd, J = 20.4, 6.4 Hz, 1H), 2.58 (dd, J = 12.4, 4.0 Hz, 1H), 2.43 (s, 3H), 2.29 (s, 3H), 2.25 (td, J = 12.4, 2.0 Hz, 1H), 2.06 (td, J = 12.4, 5.2 Hz, 1H), 1.97 (s, 3H), 1.81 (dd, J = 12.6, 2.0 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 170.1, 167.9, 154.3, 139.4, 133.2, 133.1, 131.5, 130.9, 129.3, 121.5, 94.8, 58.0, 49.2, 46.2, 44.4, 43.2, 39.2, 35.9, 23.2, 21.3, 20.6; MS (ESI) m/z 414.2 [M + H]; HRMS (ESI) m/z calcd for C21H24N3O6 414.1660; found 414.1658.
N-((4R,4aR,7R,7aR,12bS)-9-Hydroxy-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (8): From 6 as a yellow foam; [α]D20 −125.4° (c 0.94, CHCl3:MeOH 9:1). 1H NMR (400 MHz, CDCl3+CD3OD) δ 7.57 (s, 1H), 5.71 (m, 1H), 5.56 (dd, J = 10.0, 1.6 Hz, 1H), 4.65 (s, 1H), 4.29 (d, J = 5.6 Hz, 1H), 3.42 (d, J = 20.0 Hz, 1H), 3.30 (m, 1H), 2.85 (s, 1H), 2.54 (td, J = 20.4, 6.0 Hz, 2H), 2.39 (s, 3H), 2.22 (m, 1H), 1.94 (m, 1H), 1.93 (s, 3H), 1.73 (dd, J = 12.6, 1.6 Hz, 1H). 13C NMR (100 MHz, CDCl3+CD3OD) δ 171.4, 150.4, 139.7, 139.6, 132.1, 131.0, 128.6, 123.5, 115.4, 94.3, 58.2, 49.9, 46.4, 43.9, 42.7, 38.2, 35.3, 22.4, 20.7; MS (ESI) m/z 372.2 [M + H]; HRMS (ESI) m/z calcd for C19H22N3O5 372.1554; found 372.1554.
Acetamide8from12: To a solution of TBS ether 12 (0.8 g, 1.6 mmol) in THF (20 mL) was added a solution of TBAF (1 M in THF, 2 mL) and the solution was stirred at room temperature for 0.5 h. The solvent was evaporated, and the residue was purified by flash chromatography (CHCl3:MeOH:28% NH4OH, 80:18:2) to give 8 (0.55 g, 92.5%).
N-((4R,4aR,7R,7aR,12bS)-9-Hydroxy-3-methyl-10,11-dinitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (9): From 6 as a yellow solid; MS (ESI) m/z 417.1 [M + H]; HRMS (ESI) m/z calcd for C19H21N4O7 417.1405; found 417.1403.
N-((4R,4aR,7R,7aR,12bS)-9-((tert-Butyldimethylsilyl)oxy)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (11). To a solution of acetate 6 (1.33 g, 3.6 mmol) in MeOH (20 mL) was added K2CO3 powder and the mixture was stirred for 1 h at 50 °C. The mixture was filtered and the filtrate was concentrated to give the crude intermediate 10 (N-((4R,4aR,7R,7aR,12bS)-9-hydroxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide). The crude phenol 10 was dissolved in CH2Cl2 (50 mL). Imidazole (294 mg, 4.3 mmol) was added, followed by TBSCl (650 mg, 4.3 mmol). The solution was stirred at room temperature for 2 h, washed with H2O and brine and dried over anhydrous Na2SO4. After filtration and removal of solvent in vacuo, the crude product was purified by purified by flash chromatography (CHCl3:MeOH:28% NH4OH, 95:4.5:0.5) to afford 11 (1.52 g, 96.2% over 2 steps) as a yellow foam. [α]D20 −170.0° (c 0.99, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.58 (d, J = 8.0 Hz, 1H), 6.44 (d, J = 8.4 Hz, 1H), 5.79 (m, 1H), 5.60 (dd, J = 10.0, 2.0 Hz, 1H), 5.33 (d, J = 6.8 Hz, 1H), 4.70 (s, 1H), 4.41 (t, J = 6.8 Hz, 1H), 3.30 (dd, J = 6.4, 4.0 Hz, 1H), 3.00 (d, J = 18.8 Hz, 1H), 2.90 (s, 1H), 2.54 (dd, J = 12.0, 4.4 Hz, 1H), 2.42 (s, 3H), 2.34 (m, 2H), 1.96 (m, 4H), 1.79 (dd, J = 12.4, 2.0 Hz, 1H), 0.96 (s, 9H), 0.18 (s, 3H), 0.16 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 169.7, 148.1, 137.4, 133.4, 130.5, 129.0, 127.5, 121.5, 118.9, 92.3, 59.2, 49.7, 47.0, 44.3, 43.2, 40.6, 36.4, 25.9 (3), 23.4, 20.4, 18.5, 4.42, 4.38; MS (ESI): m/z 441.2 [M + H]; HRMS (ESI) m/z calcd for C25H37N2O3Si 441.2568; found 441.2569.
N-((4R,4aR,7R,7aR,12bS)-9-((tert-Butyldimethylsilyl)oxy)-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (12). To a solution of TBS ether 11 (1.46 g, 3.3 mmol) in AcOH (20 mL) was added bismuth (III) nitrate pentahydrate (1.93 g, 4.2 mmol) and the mixture was stirred at room temperature overnight. The solvent was evaporated, and the residue was basified with NH4OH. The mixture was extracted with CH2Cl2 (3 × 30 mL) and the combined extracts were washed with brine and dried over anhydrous Na2SO4. After filtration and removal of solvent in vacuo, the crude product was purified by flash chromatography (CHCl3:MeOH:28% NH4OH, 95:4.5:0.5) to give 12 (0.8 g, 50.0%) as a brown oil. [α]D20 −107.2° (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.60 (s, 1H), 5.83 (m, 1H), 5.66 (td, J = 10.0, 2.0 Hz, 2H), 4.86 (s, 1H), 4.40 (t, J = 6.4 Hz, 1H), 3.47 (d, J = 20.4 Hz, 1H), 3.33 (m, 1H), 2.94 (s, 1H), 2.60 (dd, J = 20.4, 2.0 Hz, 1H), 2.54 (dd, J = 12.4, 4.0 Hz, 1H), 2.40 (s, 3H), 2.23 (td, J = 12.4, 3.6 Hz, 1H), 2.02 (td, J = 12.4, 4.8 Hz, 1H), 1.96 (s, 3H), 1.74 (d, J = 10.8 Hz, 1H), 0.94 (s, 9H), 0.18 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 170.0, 153.7, 139.4, 137.5, 133.4, 132.1, 129.1, 126.4, 119.6, 93.8, 58.1, 49.2, 46.2, 44.4, 43.2, 39.3, 36.3, 25.6, 23.2, 21.0, 18.4, 4.54, 4.48; MS (ESI) m/z 486.2 [M + H]; HRMS (ESI) m/z calcd for C25H36N3O5Si 486.2419; found 486.2420.
N-((4R,4aR,7R,7aR,12bS)-9-methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (
15): Compound
15 was synthesized with a yield of 74.1% over 3 steps following the procedure of preparing compound
6 [23]. [α]
D20 −232.0° (
c 1.02, CHCl
3);
1H NMR (400 MHz, CDCl
3)
δ 6.64 (d,
J = 8.4 Hz, 1H), 6.52 (d,
J = 8.4 Hz, 1H), 5.80 (m, 1H), 5.59 (dd,
J = 10.0, 1.6 Hz, 1H), 5.55 (d,
J = 6.8 Hz, 1H), 4.74 (s, 1H), 4.40 (t,
J = 6.8 Hz, 1H), 3.83 (s, 3H), 3.30 (m, 1H), 3.20 (d,
J = 18.4 Hz, 1H), 2.94 (s, 1H), 2.53 (dd,
J = 12.0, 4.4 Hz, 1H), 2.41 (s, 3H), 2.30 (m, 2H), 2.00 (m, 1H), 1.95 (s, 3H), 1.80 (d,
J = 10.8 Hz, 1H);
13C NMR (100 MHz, CDCl
3)
δ 169.8, 146.1, 142.3, 132.8, 130.5, 129.1, 127.2, 118.9, 113.9, 92.5, 59.1, 56.8, 49.9, 47.0, 44.1, 43.2, 40.4, 36.2, 23.3, 20.3; MS (ESI):
m/
z = 341.2 [M + H]
+. HRMS (ESI)
m/
z calcd for C
20H
25N
3O
2 341.1860; found, 341.1860.
N-((4R,4aR,7R,7aR,12bS)-9-Methoxy-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (16): To a solution of methyl ether 15 (1.2 g, 3.5 mmol) in AcOH (60 mL) was added bismuth(III) nitrate pentahydrate (2.04 g, 4.2 mmol) and the mixture was stirred at room temperature overnight. The solvent was evaporated and the residue was basified with NH4OH. The mixture was diluted with CH2Cl2 (100 mL) and filtered on a pad of celite. The two-layer filtrate was separated, and the aqueous layer was extracted with CH2Cl2 (3 × 30 mL) and the combined extracts were washed with brine and dried over anhydrous Na2SO4. After filtration and evaporation, the crude product was purified by flash chromatography (CHCl3:MeOH:NH4OH, 95:4.5:0.5) to yield 16 (1.19 g, 88.2%) as a yellow foam. A sample was crystallized from MeOH for analysis. 1H NMR (400 MHz, CDCl3) δ 7.65 (s, 1H), 5.84 (m, 1H), 5.78 (d, J = 6.8 Hz, 1H), 5.64 (dd, J = 10.0, 1.6 Hz, 1H), 4.91 (s, 1H), 4.40 (t, J = 6.4 Hz, 1H), 3.86 (s, 3H), 3.48 (d, J = 20.0 Hz, 1H), 3.34 (m, 1H), 2.97 (s, 1H), 2.61 (dd, J = 20.4, 6.0 Hz, 1H), 2.53 (dd, J = 12.0, 4.0 Hz, 1H), 2.39 (s, 3H), 2.21 (td, J = 12.4, 3.6 Hz, 1H), 2.02 (td, J = 12.4, 4.8 Hz, 1H), 1.96 (s, 3H), 1.76 (d, J = 12.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 170.0, 151.6, 142.1, 139.4, 133.0, 131.8, 129.2, 126.3, 111.0, 94.1, 58.1, 56.6, 49.3, 46.2, 44.2, 43.1, 39.3, 36.2, 23.2, 21.0; MS (ESI): m/z = 386.2 [M + H]+. HRMS (ESI) m/z: [M + H]+ calcd for C20H24N3O5 386.1710; found, 386.1713; Anal. Calcd. for C20H23N3O5•1.25 CH3OH: C, 59.99; H, 6.63; N, 9.88. Found C, 60.11; H, 6.71; N, 10.04.
N-((4R,4aR,7R,7aR,12bS)-11-Amino-9-methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (17): To a solution of nitro compound 16 (1.0 g, 2.6 mmol) in EtOH (15 mL) was added a solution of NaOH (7.5 mL, 0.31 g, 7.8 mmol). Formamidinesulfinic acid (FSA, 0.84 g, 7.8 mmol) was dissolved into a solution of NaOH (7.5 mL, 0.31 g, 7.8 mmol) and the solution was transferred to the alkaline solution of 16. The solution was heated up to 90 °C for 2 h. The solvent was evaporated, and the aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined extracts were washed with brine and dried over anhyd Na2SO4. After filtration and evaporation, the crude product was purified by flash chromatography (CHCl3:MeOH:NH4OH, 85:13.5:1.5) to give 17 (0.728 g, 78.8%) as an off-white foam. 1H NMR (400 MHz, CDCl3) δ 6.06 (s, 1H), 5.74 (m, 1H), 5.58 (d, J = 7.2 Hz, 1H), 5.54 (dd, J = 9.6, 1.6 Hz, 1H), 4.64 (s, 1H), 4.33 (t, J = 6.4 Hz, 1H), 3.77 (s, 3H), 3.35 (m, 3H), 2.89 (s, 1H), 2.69 (d, J = 18.4, 6.0 Hz, 1H), 2.52 (dd, J = 12.0, 4.0 Hz, 1H), 2.39 (s, 3H), 2.30 (td, J = 12.4, 3.6 Hz, 1H), 2.05 (dd, J = 14.0, 6.0 Hz, 1H), 1.95 (td, J = 12.4, 4.8 Hz, 1H), 1.92 (s, 3H), 1.79 (dd, J = 12.6, 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 169.7, 142.7, 139.0, 137.1, 132.2, 131.2, 129.0, 112.4, 101.1, 92.2, 58.8, 56.8, 50.2, 47.0, 44.3, 43.2, 40.2, 35.9, 23.3, 17.1; MS (ESI): m/z 356.2 [M + H]+. HRMS (ESI) m/z: calcd for C20H26N3O3 356.1969; found, 356.1968.
N-((4R,4aR,7S,7aR,12bS)-9-Methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (
20). To a stirred suspension of codeinone oxime [
26] (
18, 3.52 g, 11.27 mmol) in anhydrous toluene (225 mL) was added Red-Al solution 65% in toluene, 56.34 mmol, 17.18 mL, 5 equiv). The solids dissolved upon addition of the Red-Al solution. The solution was heated to 70 °C for 1.5 h until the starting material was consumed as indicated by TLC and mass spectrometry. The solution was cooled to 25 °C and 5% NaOH solution (100 mL) was added. The mixture was stirred until two homogenous layers formed. The organic layer was separated, and the aqueous layer was extracted with CHCl
3 (3 × 50 mL). The combined organic extracts were dried over Na
2SO
4, filtered, and concentrated in vacuo to give intermediate
19 ((4
R,4a
R,7
S,7a
R,12b
S)-9-methoxy-3-methyl-2,3,4,4a,7,7a-hexahydro-1
H-4,12-methanobenzofuro[3,2-
e]isoquinolin-7-amine) as a pale yellow oil. The crude amine was dissolved in CHCl
3 (112 mL), and triethylamine (3.42 g, 33.81 mmol, 4.71 mL, 3 equiv) and 4-dimethylaminopyridine (0.14 g, 1.12 mmol, 0.1 equiv were added sequentially under N
2. The solution was cooled to 0 °C and acetic anhydride (2.30 g, 22.53 mmol, 2.13 mL, 2 equiv) was added in one portion. The solution was stirred for 16 h, warming to 25 °C. The solution was washed with saturated aqueous NaHCO
3 (25 mL, H
2O (25 mL), dried over Na
2SO
4, filtered, and solvent removed in vacuo to give a yellow oil. The oil was purified by column chromatography on SiO
2 (CHCl
3:MeOH:28% NH
4OH, 99:0.9:0.1 to 95:94.5:0.5) to give
20 as a clear oil (2.90 g, 75%). [α]
D20 −1.91° (
c 0.59, MeOH);
1H NMR (400 MHz, CDCl
3)
δ 6.60 (d,
J = 8.4 Hz, 1H), 6.51 (d,
J = 8.4 Hz, 1H), 6.35 (d,
J = 8.7 Hz, 1H), 5.43 (d,
J = 9.7 Hz, 1H), 5.33 (dt,
J = 9.7, 2.6 Hz, 1H), 4.78 (dd,
J = 6.2, 1.0 Hz, 1H), 4.53 (dtd,
J = 8.7, 5.7, 2.9 Hz, 1H), 3.76 (s, 3H), 3.30 (dd,
J = 6.1, 3.2 Hz, 1H), 2.99 (d,
J = 18.6 Hz, 1H), 2.68 (quintet,
J = 2.7 Hz, 1H), 2.52 (dd,
J = 12.2, 4.1 Hz, 1H), 2.38 (s, 3H), 2.34 (dt,
J = 12.2, 6.1 Hz, 1H), 2.25 (dt,
J = 17.2, 7.9 Hz, 1H), 2.01 (dt,
J = 13.7, 7.4 Hz, 1H), 1.99 (s, 3H), 1.77 (dd,
J = 12.6, 1.6 Hz, 1H);
13C NMR (100 MHz, CDCl
3)
δ 169.7, 146.4, 141.9, 130.8, 130.6, 130.0, 127.4, 119.3, 112.5, 90.8, 58.7, 56.1, 47.1, 46.4, 43.5, 43.1, 40.8, 35.7, 23.3, 20.4; HRMS (ESI) (
m/
z) [M+H] calcd for C
20H
25N
2O
3 341.1865, found 341.1863. Anal calcd for C
20H
24N
2O
3•0.45 CHCl
3: C, 62.32; H, 6.25; N, 7.11; Found C, 62.01; H, 6.61; N, 7.02.
N-((4R,4aR,7S,7aR,12bS)-9-Methoxy-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (21). Amide 20 (2.97 g, 8.72 mmol) was dissolved in acetic acid (174 mL) under N2. The solution was cooled to 10 °C and freshly ground bismuth(III) nitrate pentahydrate (5.29 g, 10.90 mmol, 1.25 equiv) was added in one portion. The solution was stirred for 16 h, warmed to 25 °C then concentrated in vacuo to give a yellow residue. The residue was made basic (pH > 9) with 28% NH4OH, and filtered through celite to remove the solid precipitate, rinsing with 10% MeOH:CHCl3. The organic layer was separated and the aqueous layer was extracted with 10% MeOH:CHCl3 (4 × 50 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo to give a yellow solid. The solid was triturated with 1:1 acetone: Et2O, filtered, and dried to give 21 as a yellow solid (1.52 g, 45%). 1H NMR (400 MHz, CDCl3) δ 7.69 (s, 1H), 6.14 (d, J = 8.7 Hz, 1H), 5.51 (dd, J = 9.7, 2.9 Hz, 1H), 5.44 (dt, J = 9.7, 2.6 Hz, 1H), 4.99 (dd, J = 6.0, 0.8 Hz, 1H), 4.69 (ddd, J = 8.6, 5.8, 2.8 Hz, 1H), 3.92 (s, 3H), 3.53 (d, J = 20.3 Hz, 1H), 3.42 (dd, J = 6.0, 3.2 Hz, 1H), 2.76 (q, J = 2.6 Hz, 1H), 2.65 (dd, J = 20.2, 6.1 Hz, 1H), 2.60 (dd, J = 10.4, 4.4 Hz, 1H), 2.46 (s, 3H), 2.32 (td, J = 12.3, 3.4 Hz, 1H), 2.13 (dd, J = 12.5, 5.1 Hz, 1H), 2.09 (s, 3H), 1.82 (dd, J = 12.8, 1.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 169.7, 151.8, 141.8, 139.9, 132.2, 130.8, 130.3, 126.5, 110.2, 92.8, 57.8, 56.3, 47.2, 45.7, 43.8, 43.1, 40.1, 35.7, 23.3, 21.3; HRMS (ESI) (m/z) [M+H] calcd for C20H24N3 386.1716, found 386.1712. Anal calcd for C20H23N3O5•0.25 H2O: C, 61.61; H, 6.07; N, 10.78; found C, 61.67; H, 6.06; N, 10.67.
N-((4R,4aR,7S,7aR,12bS)-9-Hydroxy-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (22). Under nitrogen, amide 21 (0.50 g, 1.41 mmol) in anhyd CH2Cl2 (28 mL) was cooled to −78 °C and BBr3 (2.11 g, 8.44 mmol, 0.80 mL, 6 equiv) was added dropwise. The solution was stirred for 16 h, warming to 25 °C. The solution was cooled to 0 °C and MeOH (10 mL) was added to neutralize the remaining BBr3. The solution was concentrated in vacuo and then stripped with MeOH (20 mL × 3) to give a yellow solid. The solid was dissolved in MeOH and purified via silica gel chromatography (CHCl3:MeOH:28% NH4OH, 92:1.8:0.2 to 90:9:1) to give 22 as a yellow solid (0.40 g, 77%).1H NMR (400 MHz; CDCl3) δ 7.64 (s, 1H), 6.74 (d, J = 8.7 Hz, 1H), 5.53 (d, J = 9.8 Hz, 1H), 5.45 (dt, J = 9.5, 2.4 Hz, 1H), 5.00 (d, J = 5.8 Hz, 1H), 4.65 (dt, J = 5.6, 2.9 Hz, 1H), 3.50 (m, 2H), 2.81 (t, J = 2.2 Hz, 1H), 2.73–2.66 (m, 2H), 2.49 (s, 3H), 2.40–2.39 (m, 1H), 2.16–2.12 (m, 1H), 2.09 (s, 3H), 1.83 (d, J = 11.4 Hz, 1H); 13C NMR (100 MHz; CDCl3) δ 170.7, 151.5, 139.9, 139.2, 132.0, 130.4, 130.2, 124.5, 114.9, 92.0, 58.0, 47.5, 45.7, 43.6, 42.8, 39.5, 35.1, 23.1, 21.6.
N-((4R,4aR,7S,7aR,12bS)-9-((tert-Butyldiphenylsilyl)oxy)-3-methyl-11-nitro-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (23). Phenol 22 (0.20 g, 0.54 mmol) was dissolved in CHCl3 (5 mL) under N2, and imidazole (0.15 g, 2.15 mmol, 4 equiv) and tert-butyldimethylsilyl chloride (0.30 g, 1.10 mmol, 0.28 mL, 2 equiv) were added sequentially. The solution was heated to 50 °C until TLC indicated that the starting material was consumed. The solution was cooled, concentrated and purified via silica gel chromatography (CHCl3:MeOH:28% NH4OH, 99:0.9:0.1 to 95:94.5:0.5) to give 23 as a yellow oil that solidified upon standing (0.274 g, 83%).[α]D20 −0.545° (c 0.46, MeOH); 1H NMR (400 MHz; CDCl3) δ 7.70–7.63 (m, 5H), 7.45–7.41 (m, 2H), 7.39–7.34 (m, 4H), 5.41 (d, J = 8.9 Hz, 1H), 5.36 (dt, J = 9.7, 2.7 Hz, 1H), 5.24 (d, J = 9.7 Hz, 1H), 4.64 (dd, J = 5.9, 0.9 Hz, 1H), 4.48 (ddd, J = 8.7, 5.9, 2.9 Hz, 1H), 3.45 (d, J = 20.3 Hz, 1H), 3.34 (dd, J = 6.0, 3.2 Hz, 1H), 2.65 (t, J = 2.7 Hz, 1H), 2.56 (td, J = 17.1, 5.7 Hz, 2H), 2.41 (s, 3H), 2.23 (td, J = 12.4, 3.5 Hz, 1H), 1.96 (td, J = 12.5, 5.1 Hz, 1H), 1.76 (s, 3H), 1.54 (dd, J = 12.7, 1.6 Hz, 1H), 1.14 (s, 9H); 13C NMR (100 MHz; CDCl3) δ 169.4, 153.8, 139.7, 137.0, 135.2, 132.6, 132.4, 130.3, 130.3, 130.2, 128.0, 126.6, 118.992.1, 57.7, 47.0, 45.6, 43.7, 43.1, 40.0, 35.5, 26.4, 23.0, 21.3, 19.6; HRMS (ESI) (m/z) [M+H] calcd for C35H40N3O5Si 610.2737, found 610.2740. Anal calcd for C35H39N3O5Si•0.25 CHCl3: C, 66.19; H, 6.19; N, 6.57, found C, 66.07; H, 6.28; N, 6.48.
N-((4R,4aR,7S,7aR,12bS)-7-acetamido-9-((tert-butyldiphenylsilyl)oxy)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-11-yl)-3-(tritylthio)propanamide (25). A solution of amide 23 (0.165 g, 0.271 mmol), EtOH (5.40 mL), and stannous chloride dihydrate (0.305 g, 1.35 mmol, 5 equiv) was heated to 60 °C for 10 min, then sodium borohydride (0.005 g, 0.135 mmol, 0.5 equiv) was added in one portion. The mixture was stirred for 2 h, then the temperature was increased to 65 °C and a second portion of sodium borohydride (0.005 g, 0.135 mmol, 0.5 equiv) was added. The solution was stirred at 65 °C for 16 h, at which point TLC analysis indicated that the starting material had been consumed. The solution was concentrated in vacuo and the excess hydride was neutralized by addition of cold 5% NaHCO3 solution (10 mL). The aqueous solution was extracted with 10% MeOH:CHCl3 (3 × 10 mL), and the combined organic extracts were dried over Na2SO4, filtered, and concd in vacuo to give the crude intermediate aniline (24) as clear oil that was used without purification in the subsequent reaction. The crude aniline 24 was dissolved in CHCl3 (5 mL), and triethylamine (0.109 g, 1.08 mmol, 0.150 mL, 4 equiv) and 3-(tritylthio)propanoic acid (0.189 g, 0.541 mmol, 2 equiv) were added sequentially. The solution was cooled to 0 °C and TBTU (0.347 g, 1.08 mmol, 4 equiv) was added in one portion. The solution was stirred for 16 h, warming to 25 °C, then washed with H2O (2 × 5 mL). The combined aqueous layers were back extracted with CHCl3 (2 × 5 mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo to give a yellow oil. The oil was purified via silica gel chromatography (CHCl3:MeOH:28% NH4OH, 99:0.9:0.1 to 95:94.5:0.5) to give 25 as a clear oil (0.116 g, 46%).1H NMR (400 MHz; CDCl3) δ 7.70 (dd, J = 13.3, 6.9 Hz, 4H), 7.44–7.27 (m, 15H), 7.21 (dd, J = 16.9, 9.8 Hz, 5H), 6.86 (s, 1H), 6.76 (s, 1H), 5.59 (d, J = 8.8 Hz, 1H), 5.27–5.20 (m, 2H), 4.53 (d, J = 6.0 Hz, 1H), 4.40 (d, J = 6.0 Hz, 1H), 3.27 (dd, J = 5.4, 3.0 Hz, 1H), 2.81 (d, J = 18.5 Hz, 1H), 2.62–2.48 (m, 4H), 2.33–2.26 (m, 4H), 2.13–2.08 (m, 2H), 1.95 (m, 2H), 1.71 (s, 3H), 1.62 (d, J = 11.9 Hz, 1H), 1.12 (s, 9H); 13C NMR (100 MHz; CDCl3) δ 169.5, 168.8, 146.2, 144.6, 136.8, 135.30, 135.26, 133.5, 133.2, 131.2, 130.3, 129.94, 129.85, 129.5, 127.96, 127.80, 127.6, 127.3, 126.7, 121.8, 115.8, 90.5, 67.0, 58.4, 47.0, 46.2, 43.7, 43.1, 40.7, 36.2, 35.6, 27.9, 26.5, 26.4, 23.0, 19.7, 18.3.
(4R,4aR,7S,7aR,12bS)-7-(Benzylamino)-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol (
26). To a solution of hydromorphone [
31,
32] (2.28 g, 8.0 mmol) in DCE (60 mL) was added benzylamine (0.96 mL, 8.8 mmol, 1.1 equiv), acetic acid (0.91 mL, 16.0 mmol, 2 equiv), and NaBH(OAc)
3 (2.54 g, 1.2 mmol, 1.5 equiv), respectively. The mixture was stirred at room temperature for 24 h. Water (20 mL) was added to the reaction mixture, and it was basified to a pH ~8 with 28% NH
4OH. The organic layer was separated, and the aqueous layer was extracted with CHCl
3 (3 × 25 mL). The combined organic layers were washed with brine, dried over MgSO
4, filtered, concentrated in vacuo, and the product was purified through silica gel chromatography (CHCl
3:MeOH:28% NH
4OH, 90:9:1)) to give
26 (2.85 g, 95% yield) as a light-yellow foam. [α]
20D −184.3° (
c 1.9, CHCl
3);
1H NMR (400 MHz, CDCl
3)
δ 7.38–7.19 (m, 5H), 6.65 (d,
J = 8.0 Hz, 1H), 6.50 (d,
J = 8.0 Hz, 1H), 4.63 (d,
J = 3.4 Hz, 1H), 3.90 (dd,
J = 41.7, 13.0 Hz, 2H), 3.04 (dd,
J = 6.1, 2.5 Hz, 1H), 2.91 (d,
J = 18.6 Hz, 1H), 2.71–2.75 (m, 1H), 2.49 (dd,
J = 12.0, 4.2 Hz, 1H), 2.36 (s, 3H), 2.35–2.24 (m, 2H), 2.16–2.12 (m, 1H), 1.84 (td,
J = 12.4, 5.0 Hz, 1H), 1.68–1.43 (m, 3H), 0.92–0.77 (m, 2H);
13C NMR (400 MHz, CDCl
3)
δ 145.9, 139.2, 138.0, 129.6, 128.5, 128.4, 128.4, 127.1, 126.1, 119.2, 118.0, 89.1, 59.6, 53.6, 50.4, 46.1, 43.0, 42.7, 38.0, 36.0, 21.4, 20.7, 19.9; HRMS (ESI)
m/
z 377.2224 [C
24H
29N
2O
2 (M+H) requires 377.2229].
N-((4R,4aR,7S,7aR,12bS)-9-hydroxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (29). To a solution of 26 (3.0 g, 7.9 mmol) in MeOH (100 mL) in a 500 mL hydrogenation bottle was added 10% (w/w) Pd/C (1.5 g) and 37% HCl (1.5 mL). The reaction was stirred under H2 (50 psi) for 4 days at 40 °C. The reaction mixture was filtered through a Celite pad, and concentrated under vacuo to give a yellow solid amine 27 (4R,4aR,7S,7aR,12bS)-7-amino-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol). To the intermediate 27, DCM (25 mL), triethylamine (5.7, 41.1 mmol), and Ac2O (5.1 mL, 54 mmol) were added, respectively. The reaction mixture was stirred for 16 h at 40 °C, cooled to room temperature, and H2O (30 mL) was added to the reaction mixture. The mixture was basified to pH ~8.5 with 28% NH4OH and extracted with CHCl3:2-propanol (9:1) (3 × 30 mL). The combined organic layers were concentrated in vacuo to give a thick viscous syrupy amide 28 ((4R,4aR,7S,7aR,12bS)-7-acetamido-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl acetate). The syrup was dissolved in MeOH (30 mL) and 6 M NaOH (4 mL) and stirred at room temperature for 1 h. The reaction mixture was concentrated in vacuo, dissolved in CHCl3 (40 mL), and extracted with 2 M NaOH (3 × 20 mL). The combined aqueous layers were acidified to pH < 4 with 37%. HCl, and then re-basified to pH ~8.5 with 28% NH4OH. The aqueous solution was extracted with CHCl3:MeOH (8:1) (3 × 50 mL) and the combined organic layers were dried over MgSO4, filtered, and the solvent removed in vacuo to provide 29 (1.92 g, 70% yield) as a light yellow solid. White crystals were obtained after recrystallization in DCM and hexane, mp 137–142 °C. [α]20D −167.5° (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.68 (d, J = 8.1 Hz, 1H), 6.56 (d, J = 8.1 Hz, 1H), 6.10 (d, J = 9.0 Hz, 1H), 4.62 (d, J = 4.6 Hz, 1H), 4.28–4.21 (m, 1H), 3.14 (dd, J = 5.9, 2.5 Hz, 1H), 2.98 (d, J = 18.7 Hz, 1H), 2.55 (dd, J = 12.1, 3.9 Hz, 1H), 2.47–2.37 (m, 4H), 2.35–2.27 (m, 2H), 2.03–1.93 (m, 4H), 1.73–1.64 (m, 2H), 1.51–1.43 (m, 1H), 1.10 –1.04 (m, 1H), 0.94–0.83 (m, 1H); 13C NMR (400 MHz, CDCl3) δ 169.9, 145.4, 138.0, 129.7, 126.4, 119.5, 117.1, 89.7, 59.6, 46.7, 46.2, 42.8, 42.7, 37.0, 36.4, 23.3, 22.5, 20.3, 20.0; HRMS (ESI) m/z 329.1861 [C19H25N2O3 (M+H) requires 329.1865].
N-((4R,4aR,7S,7aR,12bS)-9-((tert-butyldimethylsilyl)oxy)-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (30). To a solution of 29 (1.0 g, 3.0 mmol) in DCM (25 mL) was added 1H-imidazole (0.23 g, 3.3 mmol, 1.1 equiv) and tert-butyldimethylsilyl chloride (TBS-Cl, 0.60 g, 4.0 mmol, 1.3 equiv) and the mixture was stirred overnight at room temperature. The reaction was quenched with saturated NaCO3H, and extracted with CHCl3 (3 × 25 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered, the solvent removed in vacuo, and the product was purified through silica gel chromatography (CHCl3:MeOH:28% NH4OH, 90:9:1) to give 30 (1.22 g, 91% yield) as a white solid, mp 176–178 °C. [α]20D −146° (c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.65 (d, J = 8.1 Hz, 1H), 6.54 (d, J = 8.1 Hz, 1H), 5.81 (d, J = 8.7 Hz, 1H), 4.58 (d, J = 4.4 Hz, 1H), 4.21–4.08 (m, 1H), 3.08 (dd, J = 6.1, 2.7 Hz, 1H), 2.95 (d, J = 18.7 Hz, 1H), 2.48 (dd, J = 12.2, 4.5 Hz, 1H), 2.43–2.34 (m, 4H), 2.31–2.20 (m, 2H), 1.95 (s, 3H), 1.90 (dd, J = 12.4, 5.1 Hz, 1H), 1.80–1.62 (m, 2H), 1.53–1.47 (m, 1H), 1.02 (s, 9H), 0.94–0.84 (m, 2H), 0.23 (s, 3H), 0.18 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 169.1, 148.2, 136.4, 130.3, 128.4, 121.3, 119.2, 89.6, 59.6, 46.8, 46.1, 43.1, 42.8, 37.6, 35.9, 25.6, 23.3, 22.0, 20.4, 19.9, 18.3, −4.2, −4.5. HRMS (ESI) m/z 443.2725 [C24H29N2O2 (M+H) requires 443.2729].
N-((4R,4aR,7S,7aR,12bS)-9-((tert-butyldimethylsilyl)oxy)-3-methyl-11-nitro-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (31). To a stirred solution of 30 (860 mg, 1.94 mmol) in trifluoroacetic acid (10 mL) at 0 °C was added NaNO2 (174 mg, 2.52 mmol, 1.3 equiv). The reaction mixture was stirred for 30 min at 0 °C, slowly basified to pH ~8.5 with 28% NH4OH, and extracted with CHCl3:2-propanol (8:1) (4 × 25 mL). The combined organic layers were dried over MgSO4, filtered, concentrated in vacuo, and the product was purified through silica gel chromatography (CHCl3:MeOH:28% NH4OH, 90:9:1)) to give 31 (710 mg, 75% yield) as light green foam. [α]20D −142.0° (c 1.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 5.65 (d, J = 8.6 Hz, 1H), 4.78 (dd, J = 4.4, 1.1 Hz, 1H), 4.27–4.19 (m, 1H), 3.41 (d, J = 20.3 Hz, 1H), 3.15 (dd, J = 6.1, 2.9 Hz, 1H), 2.77 (dd, J = 20.3, 6.2 Hz, 1H), 2.52 (dd, J = 12.4, 4.2 Hz, 1H), 2.42 (s, 3H), 2.32 (td, J = 9.4, 2.8 Hz, 1H), 2.20 (td, J = 12.3, 3.5 Hz, 1H), 2.05–1.91 (m, 4H), 1.88–1.72 (m, 2H), 1.71–1.51 (m, 2H), 1.03 (s, 9H), 0.99–0.81 (m, 2H), 0.27 (s, 3H), 0.23 (s, 3H); 13C NMR (400 MHz, CDCl3) δ 169.2, 154.0, 139.7, 136.7, 131.9, 127.1, 119.6, 91.5, 58.8, 46.5, 45.4, 43.2, 42.9, 37.7, 35.0, 25.5, 23.3, 21.7, 20.6, 20.2, 18.3, −4.3, −4.5; HRMS (ESI) m/z 488.2575 [C25H38N3O5Si (M+H) requires 488.2581].
N-((4R,4aR,7S,7aR,12bS)-9-hydroxy-3-methyl-11-nitro-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (32). To a solution of 31 (487 mg, 1.0 mmol) in THF (3 mL) was added 3 M HCl (2 mL), and the mixture was stirred for 1 h at 60 °C. After cooling to room temperature, the reaction mixture was basified to pH~8 with 28%. NH4OH and extracted with CHCl3:MeOH (5:1) (3 × 20 mL). The combined organic layers were dried over MgSO4, filtered, concd in vacuo, and purified through silica gel chromatography (CHCl3:MeOH:28% NH4OH, 90:9:1)) to give the phenol 32 (354 mg, 9% yield) as an orange solid, mp 170–175 °C. [α]20D −187.3° (c 2.25, CHCl3); HRMS (ESI) m/z 374.1710 [C19H24N3O5 (M+H) requires 374.1716]. 1H NMR (400 MHz, CDCl3) δ 9.63 (br, 1H), 7.75 (s, 1H), 6.40 (d, J = 8.3 Hz, 1H), 4.83 (d, J = 4.0 Hz, 1H), 4.30 (m, 1H), 3.44 (d, J = 20.0 Hz, 1H), 3.30 (s, 1H), 2.87 (d, J = 14.5 Hz, 1H), 2.67 (d, J = 8.0 Hz, 1H), 2.56–2.40 (m, 4H), 2.38–2.25 (m, 1H), 2.12–2.03 (m, 4H), 1.80–1.71 (m, 2H), 1.59–1.49 (m, 1H), 1.18 – 1.07 (m, 1H), 1.04–0.93 (m, 1H); 13C NMR (400 MHz, CDCl3) δ 170.4, 151.8, 139.9, 139.7, 130.8, 124.0, 115.4, 91.0, 58.9, 46.6, 45.5, 42.7, 42.6, 36.8, 35.0, 23.2, 21.7, 21.1, 20.1.
N-((4R,4aR,7R,7aR,12bS)-11-amino-9-hydroxy-3-methyl-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)acetamide (34). To a solution of acetamide 8 (0.25 g, 0.67 mmol) in MeOH (50 mL) was added 10% Pd/C (50 mg). The mixture was hydrogenated under a hydrogen balloon overnight, filtered on a pad of celite and the filtrate was concentrated in vacuo. The product was purified by flash chromatography (CHCl3:MeOH:28% NH4OH, 80:18:2) to give 34 (105 mg, 45.6%) as a white foam. [α]D20 −147.1° (c 1.0, MeOH); 1H NMR (400 MHz, CDCl3+CD3OD) δ 5.99 (s, 1H), 4.08 (d, J = 8.0 Hz, 1H), 3.46 (m, 1H), 3.25 (s, 1H), 3.02 (s, 1H), 2.61 (d, J = 18.0 Hz, 1H), 2.39 (d, J = 11.2 Hz, 1H), 2.25 (s, 3H), 2.08 (t, J = 12.0 Hz, 1H), 1.98 (m, 2H), 1.81 (s, 3H), 1.62 (m, 2H), 1.52 (d, J = 12.0 Hz, 1H), 1.35 (d, J = 12.4 Hz, 1H), 1.08 (m, 1H), 0.88 (m, 1H). 13C NMR (100 MHz, CDCl3+CD3OD) δ 171.3, 140.5, 137.0, 136.0, 129.7, 110.8, 104.5, 92.6, 59.0, 51.4, 47.1, 43.3, 42.3, 41.8, 34.8, 28.7, 23.8, 22.7, 16.7; MS (ESI): m/z = 344.2 [M + H]. HRMS (ESI) m/z: calcd for C19H26N3O3 344.1969; found, 344.1969.
X-ray crystallographic data for compound16. Single-crystal X-ray diffraction data on compound
16 (deposition CCDC 1554589) were collected using Cu Kα radiation and a Bruker PLATINUM 135 CCD area detector. The crystal was prepared for data collection by coating with high viscosity microscope oil. The oil-coated crystal was mounted on a micro-mesh mount (MiteGen, Inc.) and transferred to the diffractometer and a data set collected at 150 °K. The 0.373 × 0.343 × 0.281 mm
3 crystal was monoclinic in space group P2
1, with unit cell dimensions a = 7.39130(10) Å, b = 9.4942(2) Å, c = 13.1498(3) Å,
α = 90°,
β = 92.8700(10)°, and
γ = 90°. Data were 94.5% complete to 67.679° θ (~0.83 Å) with an average redundancy of 3.00. The final anisotropic full-matrix least-squares refinement on F
2 with 257 variables converged at R
1 = 3.94%, for the observed data and wR2 = 9.13% for all data. The structure was solved by direct methods and refined by full-matrix least squares on F
2 values using the programs found in the SHELXL suite (Bruker, SHELXL v2014.7, 2014, Bruker AXS Inc., Madison, WI, USA). Corrections were applied for Lorentz, polarization, and absorption effects. Parameters refined included atomic coordinates and anisotropic thermal parameters for all non-hydrogen atoms. The H atoms were included using a riding model. Complete information on data collection and refinement is available in the
Supplementary Material.